Agenda & Learning Objectives


Participants in this program will be able to:
  • Discuss current research in the area of Microbiome and IBD
  • Consider organoids and organoid co-culture models in IBD from an International and Canadian perspective
  • Understand mucosal immunological research in IBD from an International and Canadian perspective
  • Interpret epigenetics and molecular mechanisms of IBD disease from an International and Canadian perspective
Time
Title/Topic
Speakers/Facilitators
08:30 EST  Opening Remarks 
Welcome, program objectives		 Lori Radke, CCC CEO
CO-CHAIRS:  Laura Sly & Bruce Vallance

(1) Microbiome in IBD Session Chair: Laura Sly
08:40 EST 1.1 Plenary Presentation
Microbiome in IBD
 Deanna Gibson
09:25 EST
1.2 Plenary Presentation
Microbiome in IBD
 Premik Bercik
09:45 EST 1.3 Expert Panel Discussion/Q&A SESSION CHAIR: Laura Sly
PANEL: Premik Bercki, Deanna Gibson
10:05 EST Refreshment and Network Break (15 mins)  

(2) Organoids and Organoid Co-Culture Models Session Chair: Bruce Vallance
10:20 EST 2.1 Plenary Presentation
Organoids and Organoid Co-Culture Models - An International Perspective
 Nicholas Zachos
 
11:05 EST
2.2 Plenary Presentation
Organoids and Organoid Co-Culture Models - A Canadian Perspective
 Simon Hirota
11:25 EST 2.3 Expert Panel Discussion/Q&A SESSION CHAIR: Bruce Vallance
PANEL: Simon Hirota, Nicholas Zachos
11:45 EST Lunch (60 mins)  

(3) Mucosal Immunology  Session Chair: Gregory Fairn
12:45 EST 3.1 Plenary Presentation
Mucosal Immunology - An International Perspective

Kevin Maloy
13:30 EST 3.2 Plenary Presentation
Mucosal Immunology - A Canadian Perspective
Heather Armstrong
13:50 EST 3.3 Expert Panel Discussion/Q&A MODERATOR: TBC
PANEL: Heather Armstrong, Kevin Maloy
14:10 EST Refreshment and Network Break (15 mins)  

(4) Epigenetics and Molecular Mechanisms of Disease  Session CHAIR: Jean-Eric Ghia
14:25 EST 4.1 Plenary Presentation
Epigenetics - An International Perspective
 Klaus Kaestner
15:10 EST 4.2 Plenary Presentation 
Epigenetics - A Canadian Perspective
 Daniel DeCarvalho
15:30 EST 4.3 Ask the Expert Panel Discussion/Q&A SESSION CHAIR: TBC
PANEL: DeCarvalho, Klaus Kaestner
15:50 EST CCC: New Funding opportunities to be announced   MODERATOR: Kate Lee, CCC
16:20 EST Closing Remarks and Program Evaluation CO-CHAIRS: Laura Sly & Bruce Vallance

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.